Podcasts about disorders

Get the AD-FREE version of my sessions - PLUS playlists, repeat options, offline access, and THOUSANDS more sessions for day, sleep, and deep 4-hour sleep at https://www.freehypnosis.app Feeling heavy, low, or unmotivated during the darker months? This hypnotic meditation is designed to help you overcome Seasonal Affective Disorder (SAD) and reignite your inner light.  

Dr. Pejman Katiraei discusses Neurodevelopment Disorders in Children with Dr. Ben Weitz.   [If you enjoy this podcast, please give us a rating and review on Apple Podcasts, so more people will find The Rational Wellness Podcast. Also check out the video version on my WeitzChiro YouTube page.]    Podcast Highlights     Dr. Pejman Katiraei is an Integrative Pediatrician and his Santa Monica practice is called Wholistic Kids and Families.  He got his undergraduate degree from UCLA and he obtained his osteopathic medical degree from Western University and completed a pediatric residency at Loma Linda University and he has also completed two fellowships in integrative medicine. Dr. Ben Weitz is available for Functional Nutrition consultations specializing in Functional Gastrointestinal Disorders like IBS/SIBO and Reflux and also Cardiometabolic Risk Factors like elevated lipids, high blood sugar, and high blood pressure.  Dr. Weitz has also successfully helped many patients with managing their weight and improving their athletic performance, as well as sports chiropractic work by calling his Santa Monica office 310-395-3111.

Guests: Vicki R. Deal-Williams, ASHA's Chief Executive Officer, and Perry Flynn, 2026 ASHA President ElectEarn 0.10 ASHA CEUs for this episode with Speech Therapy PD: https://www.speechtherapypd.com/courses/the-future-of-slhThis episode is a collaboration with the Keys for SLPs podcast, hosted by Mary Beth Hines, MS, CCC-SLP. Michelle Dawson, MS, CCC-SLP, CLC, BCS-S joins as a co-host to welcome ASHA leadership Vicki R. Deal-Williams, MA, CCC-SLP, FASAE, CAE, ASHA's Chief Executive Officer, and Perry Flynn, MEd, CCC-SLP, BCS-CL, CTRI, ASHA-F, 2026 ASHA President Elect for an inside look at the evolving speech-language-hearing professions.Together, they will explore emerging technologies, workforce trends, and ongoing efforts to recruit and retain professionals, particularly those from BIPOC communities. The conversation will also highlight the SLP Interstate Compact and offer practical guidance for students and early-career professionals navigating the changing landscape of the field.About the Guests:Vicki Deal-Williams serves as the Chief Executive Officer for the American Speech-Language-Hearing Association (ASHA), where she has been a valued team member for more than three decades. A Certified Association Executive and distinguished Fellow of the American Society of Association Executives (ASAE), Vicki is also an ASHA certified speech-language pathologist and ASHA Fellow. Her expertise lies in cultivating leadership, aligning strategic goals with organizational priorities, and navigating teams through transformation with clarity and purpose. She is known for her ability to authentically build strong, collaborative relationships and to foster a welcoming culture where everyone feels they have a voice. Through clear vision, steady guidance, and deep commitment, she works alongside volunteer leaders and members, students, vendors, partners, and staff to advance ASHA's mission, achieve optimal results, and ensure lasting impact.Perry Flynn, MEd, CCC-SLP, BCS-CL, CTRI, is the Consultant to the North Carolina Department of Public Instruction in the area of Speech-Language Pathology and a Professor in the Department of Communication Sciences and Disorders at the University of North Carolina at Greensboro. He is a Fellow of the American Speech-Language-Hearing Association, a two-time member of ASHA's Board of Directors, and a Board Certified Specialist in Child Language. He is a Professional Association of Therapeutic Horsemanship (PATH) Certified Therapeutic Horseback Riding Instructor. He has presented several times at ASHA Conventions on the topic of recruiting and retaining men and minorities in speech-language pathology and has written several articles on the topic.

In part six of this seven-part series on FND, Dr. Jon Stone and Dr. Gabriela Gilmour discuss the prognosis of functional neurologic disorders.  Show citation:  Gelauff J, Stone J. Prognosis of functional neurologic disorders. Handb Clin Neurol. 2016;139:523-541. doi:10.1016/B978-0-12-801772-2.00043-6  Show transcript:  Dr. Jon Stone: This is Jon Stone with the Neurology Minute. Gabriela Gilmour and I are back to continue with part six of our seven-part series on FND. Today we're going to talk about prognosis. What's the outlook for people with FND? It's obviously a question that patients and relatives desperate to know the answer. Gabriela, what do you say to your patients with FND when they say, "What's going to happen to me? Dr. Gabriela Gilmour: That's a difficult question because the prognosis is variable and I'll talk in a moment about what we know about prognosis from the literature. But I think when patients ask me what's going to happen, I try to instill hope because we do know that this is a condition that can improve and it can improve, especially when patients have access to rehabilitation programs or psychotherapy or other treatment plans. So I try to emphasize that piece and emphasize hope when I'm talking about that with my patients. But if we sort of take a step back and we look at what is the overall prognosis from what we know in the literature with FND, fundamentally, FND for many is a chronic and often relapsing condition. As I mentioned, it can certainly improve with rehabilitation. A challenge is that most of our published studies on the prognosis of FND really come from a time when we knew a lot less about the condition and we had fewer treatment options. So these studies are somewhat difficult to apply today, but in these studies, we see that at least without treatment, most patients are the same or worse at follow-up. However, now we're starting to develop more rehabilitation programs and we have more evidence that shows that people certainly improve with rehabilitation and with therapy. There are some factors that I try to emphasize to patients as being good prognostic factors when I'm talking with them. These may be things like younger age, a shorter duration between symptom onset and diagnosis and patient agreement with the diagnosis or the perception of having control over their illness. When these types of things are present, I try to highlight them to, again, help build that hope for recovery. The one thing that I would also add maybe a bit of a different question, but I think is important to mention is that we as neurologists still have a lot to provide to our patients, even those who may not see much recovery in their symptoms and live with chronic illness. It's really important to consider that regular check-ins. In these check-ins, we can monitor for changing perpetuating factors. We can facilitate social services, mobility aids that help overall quality of life. We can still offer a lot to our patients. The other piece that I would mention too is that our patients are at risk of iatrogenic harm. So there is definitely a role for the neurologist to look at, are there medications that might not be indicated that are causing harm? Are there other things that we can communicate clearly with other care providers to make sure that we reduce that risk for our patients? Dr. Jon Stone: So it's about balancing some realism, but also making sure the patient doesn't lose hope. A good outcome isn't always necessarily that symptoms gone away. It might be similar to other chronic neurological conditions that we look after where we're okay with an outcome where the patient still has symptoms if they understand their condition and can learn to live with it better. We'll be back for our final Neurology Minute episode on FND with myself and Gabriela Gilmour talking about future directions in FND. Thanks for listening.

In this festive edition of Disorder, our hosts Jason Pack, Jane Kinninmont and Mark Lobel reflect on a Disorderly 2025, and preview what could be an even more Disorderly 2026. They gather around the Yuletide fire and shoot the breeze, then discuss personal Christmas traditions, the biggest moments of Disorder throughout the year, while also pointing to some moments of hope that emerged.  As they Ordered the Disorder, they highlight the need for leadership and Jason returns to his desire for a collective grass roots ordering movement pushing for towards a better future, and why human connection will help us find Order in the new year. The show closes with some beautiful cantorial music giving us some hope for the New Year, while also reflecting our sorrow over what has happened in Sydney. To join our Mega Orderers Club, and get ad free listening, early episode releases, bonus content and exclusive access to live events, visit https://disorder.supportingcast.fm/  Producer: George McDonagh Subscribe to our Substack - https://natoandtheged.substack.com/  Disorder on YouTube - https://www.youtube.com/@DisorderShow Show Notes Links: Pls Join the Mega Orderers Club for ad-free listening and early release of the episodes, via this link (and get access to our January 8th event): https://disorder.supportingcast.fm/ Join us at our live event in RUSI on January 8th (Mega Orderer membership needed for attendance) https://my.rusi.org/events/disorder-podcast-live-what-disorder-will-2026-bring.html  Yet to attend the event you need to join the Mega-Orderer's Club or the Pay For substack and RSVP through a special form available on either platform: https://natoandtheged.substack.com/p/disorder-podcast-live-with-jane-arthur  To attend Jane's UN event, visit https://www.eventbrite.co.uk/e/unga-at-80-from-1946-to-our-future-tickets-1975305412663?aff=oddtdtcreator  You can get in touch with Mark, to host or speak at your event here: https://www.mark-lobel.com/getintouch  Listen to Ep 155. Can Canada become the world's mega orderers? With Marci Surkes https://pod.link/1706818264/episode/YzQ2ZDhjNzQtYzg4NS0xMWYwLWJhMDItMzNiNDI3MTVmMDBh  Watch Jason on From Global War on Terror to the Global War on the Jews https://www.youtube.com/watch?v=0pY9KSoQDHc  The show features our looking ahead to the New Year with the Hebrew song, ‘Ba Shana HaBa'ah' song by Yoav Oved. You can check out more of his operatic cantorial singing here: https://www.youtube.com/watch?v=OolsTq5ZNNw Learn more about your ad choices. Visit megaphone.fm/adchoices

In part five of this seven-part series on FND, Dr. Jon Stone and Dr. Gabriela Gilmour discuss treatment options.  Show citation:  Gilmour, G.S., Nielsen, G., Teodoro, T. et al. Management of functional neurological disorder. J Neurol 267, 2164–2172 (2020). https://doi.org/10.1007/s00415-020-09772-w  Gilmour GS, Langer LK, Bhatt H, MacGillivray L, Lidstone SC. Factors Influencing Triage to Rehabilitation in Functional Movement Disorder. Mov Disord Clin Pract. 2024;11(5):515-525. doi:10.1002/mdc3.14007  Stone J, Carson A. Multidisciplinary Treatment for Functional Movement Disorder. Continuum (Minneap Minn). 2025;31(4):1182-1196. doi:10.1212/cont.0000000000001606 Tolchin B, Goldstein LH, Reuber M, et al. Management of Functional Seizures Practice Guideline Executive Summary: Report of the AAN Guidelines Subcommittee. Neurology. 2026;106(1):e214466. doi:10.1212/WNL.0000000000214466  Show transcript:  Dr. Jon Stone: Hello, this is Jon Stone with the Neurology Minute. Gabriela Gilmour and I are back to continue with part five of our seven-part series on FND. Today we'll be discussing treatment. Gabriela, talk us through what the rehabilitation or therapy approaches exist for FND now. Dr. Gabriela Gilmour: I would start actually even before jumping into rehabilitation and therapy to again emphasize something that we talked about in the last episode, which is that rehabilitation very much starts at our first visits with our patients when we examine for positive signs and show these to our patients and explain what they mean. So education about FND is really a fundamental treatment step, and I think we as neurologists have so much to offer to our patients in these visits. Next, when we're thinking about rehabilitation for FND, this often includes some combination of physical rehabilitation and psychological therapy and really should be individualized to each patient. So multidisciplinary or integrated therapy approaches are the gold standard and treatment strategies with these are really guided by our evolving understanding of the mechanisms of FND. So for example, this means using strategies like distraction, motor visualization, relaxation and mindfulness to target that underlying mechanism of FND. And then we use psychological therapies to also address perpetuating factors. So as we have discussed in this series, patients often experience many symptoms. So we also want to think about those other symptoms in our treatment plan, whether that be chronic pain or sleep disturbance or treating comorbid psychiatric or neurological illness. When we think about the subtypes of FND, there is some research into specific strategies for each. So psychotherapy, in particular, cognitive behavioral therapy is the focus for functional dissociative seizures with strategies aimed at attack prevention. Whereas for functional movement disorder, motor retraining physiotherapy has the most evidence. One big thing that I want to emphasize though is that rehabilitation for FND really relies on patient self-management and patient engagement. So I often explain to my patients that I can't retrain their brain, but I can help support them in this process and doing this for themselves. Dr. Jon Stone: So when you meet a patient with FND, how do you decide whether therapy is going to be helpful for them? I think people often have a tendency to say, "Oh, it's FND right off you go to psychotherapy or physiotherapy," but is that always the right option? How should we try and help our patients to decide if it's the right time for them to do these treatments? Dr. Gabriela Gilmour: Yeah, I think that that's something that's really maybe not unique, but something that's really important to FND and to treatment planning and FND. When we're supporting our patients as they embark on a treatment pathway, we really want to set them up for success. And so this really does rely on a robust triage process. So unlike other neurological conditions where you have X disease, therefore, why is the treatment? For FND, we've got a host of different types of treatments, and we want to individualize that and we want to time it right. Fundamentally, we really want to select the right treatment for our patients, and that relies on us understanding what symptoms are most bothersome to our patients, and we want to then provide that treatment at the right time. And I think right time is really what I would emphasize as being so, so important. So this means that patients are ready for active participation and rehabilitation, they're enthusiastically opted in. They think that treatment's going to help, and there aren't major barriers that are going to impact their ability to participate fully, so things like severe pain that could get in the way. And this is a conversation that I have really openly with my patients, and I really try to let them guide the timing. They will let me know, "Hey, I'm a teacher, and I'm in school right now. Now is not the right time for me to embark on this, but what about in June or July?" And then we revisit and regroup at that time. So really I do let my patients guide this process, but I would say that there are a subset of patients that don't need these more advanced rehabilitation type programs. Maybe are spontaneously improved or are able to implement some of their own self-management strategies on their own and have a significant improvement in symptoms already. Dr. Jon Stone: We need to make it easy for our patients to tell us when it's not the right time, but also, there's no one-size-fits-all, basically. Dr. Gabriela Gilmour: Absolutely. Dr. Jon Stone: So we'll be back for more Neurology Minute to continue our discussion on FND. We'll be talking about prognosis. Thanks for listening.

Listen as Jackie Carroll, health coach with UK HR Health and Wellness, guides listeners through a calming winter meditation designed to support emotional well‑being during the darker months. Through gentle reflection, you'll explore what nourishes your energy when sunlight is scarce and how small joys can bring warmth into the season.

Thank you for joining us for our 2nd Cabral HouseCall of the weekend!   I'm looking forward to sharing with you some of our community's questions that have come in over the past few weeks…   Sophie:  Hi Stephen, I really appreciate all that you do and I was hoping you would be able to give me some much needed guidance. I was diagnosed with ventricular tachycardia last year and the only explanation the consultant could provide was it was due to a tiny scar on my heart. I had a ultrasound & an MRI and the results were fine, and my heart was structurally sound. I have taken the big 5 and nothing was out of the ordinary apart from high cortisol at night and candida. I consequently completed the CBO last year. I am currently on beta blockers to control the fast/erratic heartbeats. These do not work all the time. The consultant said my only other option is for them to preform an AF abrasion. What are your thoughts on this procedure, as I really want to get off the beta Blockers and find a natural alternative to fixing my heart. I have heard you talk about how Enzymes are good for the heart, is there one in particular that would help or anything else I can try? I really do not want to have the abrasion or carry on with the BB and am desperate to find a natural solution to fixing my symptoms. I am taking omega 3, magnesium-complex, VD + K2, vitamin c, b-complex, hawthorn, zinc, coq10 & taurine, is there anything else I should be taking to help. When my symptoms are at there worst, I get a big rush to the head and black out for a few seconds, whilst shaking. I have a clean diet, and do not smoke and have cut out alcohol, coffee & sugar, as I find any stimulant does not help, including over exercising. Please help, any advise would be greatly appreciated.                                                                                                                                                                                Anonymous: Hi Dr. Cabral! Over the last year my cycle has gone from 28 days to 23–24 days, and my PMS symptoms have gotten extreme—like night sweats, heavy emotions, breast tenderness, and migraines right before my period. I'm only 34, so perimenopause feels early. Could this be stress-related, estrogen dominance, or something deeper? Thank you for all you do!                                                                                                                                                                                                   Sarah: Hello dr C! Curious if you're familiar with the eating disorder Avoidant Restrictive Food Intake Disorder (ARFID)? I suffered with it from the age of 2 until 20 - eating nothing other than 2 "safe" foods which were very processed. I'm now 29 and can happily say I no longer suffer with this ED after years of work and eat ALL the foods (all healthy, organic, wholefoods). I'm worried if having this ED for this length of time and during my developing years has permanently impacted my health, specifically my digestion and my gut microbiome. I've drastically changed my life around, have done a bunch of your testing and protocols but still dealing with some issues and curious if my past means i'll never be able to reach optimal health? How resilient is the body?                                                                          David: Hello Dr. Cabral, appreciate your work and dedication. I've been experiencing persistent muscle twitches throughout my body for about six months. My doctor says magnesium levels look "normal," but I know that doesn't always tell the full story. Could this be related to electrolytes, stress, or a nervous system imbalance? Any suggestions on testing or protocols to help calm the twitches would be appreciated.     Tommy: Hi Dr. C, I'm so frustrated. I had a gut issue for a long time and only the healthy belly product kept it at bay. Stool test showed citrabacter Freudi which I ran before I had the digestive issues. I did 2 para protocols, then the CBO, and dealt with frequent urination all the way through. By week 8, my bowells were much better and things had improved, however, I had to stop the protocol there as I couldn't handle the supplements at a lower dose. 2 weeks later I picked up a stomach bug, and since then I'm back to square one. I'm working on CBT because I have a lot of trauma and I believe that's why I've been so succeptible to stomach issues. I'm considering another stool test but the only issue is, what can I do about the result if I can't handle so many herbs and supplements I feel stuc   Thank you for tuning into this weekend's Cabral HouseCalls and be sure to check back tomorrow for our Mindset & Motivation Monday show to get your week started off right!   - - - Show Notes and Resources: StephenCabral.com/3607 - - - Get a FREE Copy of Dr. Cabral's Book: The Rain Barrel Effect - - - Join the Community & Get Your Questions Answered: CabralSupportGroup.com - - - Dr. Cabral's Most Popular At-Home Lab Tests: > Complete Minerals & Metals Test (Test for mineral imbalances & heavy metal toxicity) - - - > Complete Candida, Metabolic & Vitamins Test (Test for 75 biomarkers including yeast & bacterial gut overgrowth, as well as vitamin levels) - - - > Complete Stress, Mood & Metabolism Test (Discover your complete thyroid, adrenal, hormone, vitamin D & insulin levels) - - - > Complete Food Sensitivity Test (Find out your hidden food sensitivities) - - - > Complete Omega-3 & Inflammation Test (Discover your levels of inflammation related to your omega-6 to omega-3 levels) - - - Get Your Question Answered On An Upcoming HouseCall: StephenCabral.com/askcabral - - - Would You Take 30 Seconds To Rate & Review The Cabral Concept? The best way to help me spread our mission of true natural health is to pass on the good word, and I read and appreciate every review!  

The post 147 Organizing Testicular Disorders & beating PA School Anxiety appeared first on Physician Assistant Exam Review.

Come to a Dehoarding Accountability Zoom Session: http://www.overcomecompulsivehoarding.co.uk/ticket Subscribe to the podcast: https://www.overcomecompulsivehoarding.co.uk/subscribe Podcast show notes, links and transcript: http://www.overcomecompulsivehoarding.co.uk/  Enjoy this deep dive into the research of Sharon Morein into hoarding and ADHD. For the full show notes and transcript, see here: https://www.overcomecompulsivehoarding.co.uk/podcast-ep-40-adhd-and-hoarding-with-dr-sharon-morein/ 

Nicola Longo MD, PhDProfessor and Vice Chair of Human Genetics,Allen and Charlotte Ginsburg Chair in Precision Genomic Medicine,Division of Clinical Genetics, Department of Human Genetics,University of California at Los Angeles (UCLA), Los Angeles, CA, USAMark Roberts, MDProfessor and Consultant Neurologist,University of Manchester, Manchester, UKResearch Lead for Adult Metabolic Medicine at Salford Care Organisation, Manchester, UKDrs. Longo and Roberts discussed the current status of gene therapies in rare neuromuscular disorders in this eight part podcast series. This is derived from the symposium that was presented at World Symposium 2025, in San Diego, California, on February 4th through 7th, 2025, and is intended for healthcare professionals only. This podcast includes information about investigational compounds that do not yet have a regulatory approval or authorization for a specific indication. The safety and efficacy of the agents under investigation have not been established, and contents of this podcast shall not be used in any manner to directly or indirectly promote or sell the product for unapproved uses. The views, thoughts and opinions expressed in this presentation belong solely to the author and are subject to change without notice. The contents of this presentation do not constitute an endorsement of any product or indication by Astellas. In this part, Dr. Longo will discuss gene replacement therapy in lysosomal disorders.Nicola Longo MD, PhDLet's go back a second to gene therapy. Gene therapy obviously has the potential of answering many of the questions that we still have open in lysosomal disorder because they could restore the activity of the lysosome pretty much in the whole body, or at least in multiple tissues. As you have seen, gene therapy can be done ex vivo where we take cells from the affected patient, we correct the gene, or we put an extra gene that it is functional. Then we put them back by doing a bone marrow transplant, basically creating space for the cells that have been genetically modified to correct the lysosomal defect. The biggest approach this is done usually by lentiviruses that they integrate inside the genome.

Nicola Longo MD, PhDProfessor and Vice Chair of Human Genetics,Allen and Charlotte Ginsburg Chair in Precision Genomic Medicine,Division of Clinical Genetics, Department of Human Genetics,University of California at Los Angeles (UCLA), Los Angeles, CA, USAMark Roberts, MDProfessor and Consultant Neurologist,University of Manchester, Manchester, UKResearch Lead for Adult Metabolic Medicine at Salford Care Organisation, Manchester, UKDrs. Longo and Roberts discussed the current status of gene therapies in rare neuromuscular disorders in this eight-part podcast series. This is derived from the symposium that was presented at World Symposium 2025 in San Diego, California on February 4th through 7th, 2025, and is intended for healthcare professionals only. This podcast includes information about investigational compounds that do not yet have a regulatory approval or authorization for a specific indication. The safety and efficacy of the agents under investigation have not been established and contents of this podcast shall not be used in any manner to directly or indirectly promote or sell the product for unapproved uses. The views, thoughts, and opinions expressed in this presentation belong solely to the author and are subject to change without notice. The contents of this presentation do not constitute an endorsement of any product or indication by Astellas. In this part, Dr. Longo will discuss ongoing gene therapies in lysosomal disorders.Nicola Longo MD, PhDI'm going to present to discuss some example of ongoing gene therapy for lysosomal disorder. There are gene therapy in development for both Fabry disease and some of this involve ex vivo gene therapy, many others involve systemic administration with an AAV, Gaucher disease type 1 that affect the periphery, and Gaucher disease type 2, where the replacement should occur within the central nervous system because this condition affects the brain. There is already one approved gene therapy for lysosomal disorder, which is for the early onset metachromatic leukodystrophy. This has been approved both in Europe and now even in the United States, which consists of ex vivo gene therapy with the administration of an extra gene that restore the function of the defective enzyme. Now there are many others that are ongoing for the same indication. There are gene therapy programs for GM1 and GM2 gangliosidosis, and at least one for Krabbe disease. It is important to know that some of these condition are actually included in the recommended uniform screening panel. Basically, we would have access to patients in a timely manner for some of these conditions. Then there are several gene therapy under development for the mucopolysaccharidoses, including MPS-IH, MPS-II, MPS-IIIA and MPS-IV.There are different type of lysosomal disorders, the one caused by mutation, integral membrane protein, not enzyme within the lysosome, but protein that are present on the membrane of the lysosome. This gene therapy that have been tested, it is for cystinosis, that it is caused by a defective lysosomal and for Danon disease, which is caused by a deficiency of an integral membrane part. Finally, one lysosomal disorder, which obviously seems a metabolic condition, but it is really not, is glycogen storage disease type 2 or Pompe disease, in which there is the intralysosomal accumulation of glycogen. There are several ongoing clinical trials to try to correct the problem in this condition.Now, I'm going to discuss some of the most advanced program in the lysosomal storage disorder. This include one for Fabry, which is on an accelerated approval pathway with phase 1 and 2 data, one for Gaucher disease type 1. Obviously, I'm going to discuss the one that has been already approved for metachromatic leukodystrophy. There is one for Hunter syndrome, and the difference of the one for Hunter syndrome, it is an example of the direct administration of gene therapy within the central nervous system.Finally, there is one ongoing for glycogen storage disease type 2 or Pompe disease in adult patients. In gene therapy for metachromatic leukodystrophy, it was the first gene therapy approved for lysosomal disorder in human, and this requires harvesting the CD34 cell from affected patient and then introducing the [inaudible 00:04:32] gene back in this cell, and then placing them back inside the patient again. This has been very effective in patients who were treated early, and obviously, the treatment needs to occur before there is irreversible brain damage in this patient.In the next part, Dr. Roberts and Longo will discuss treatment with gene therapies.

In this episode of THE MENTORS RADIO, Host Dan Hesse talks with Dr. Eswar Prasad, a Professor of Economics at Cornell, a senior fellow at Brookings, and the former head of the IMF's China division, to discuss his book The Future of Money: How the Digital Revolution Is Transforming Currencies and Finance, which was chosen as a Best Book of the Year by The Economist, The Financial Times, Foreign Affairs, ProMarket, and The Week. In The Future of Money, Dr. Prasad argues that we are at an inflection point where technology is redefining what money is, who issues it, and how it moves—pushing us toward a world with less physical cash, and an ecosystem of fintech and crypto innovations that will reshape everything from household payments to the global monetary order. LISTEN TO the radio broadcast live on iHeart Radio, or to “THE MENTORS RADIO” podcast any time, anywhere, on any podcast platform – subscribe here and don't miss an episode! SHOW NOTES: ESWAR S. PRASAD: BIO: BIO: Eswar S. Prasad BOOKS: The Future of Money: How the Digital Revolution Is Transforming Currencies and Finance, by Eswar S. Prasad The Doom Loop: Why the World Economic Order Is Spiraling into Disorder, by Eswar S. Prasad Gaining Currency: The Rise of the Renminbi, by Eswar S. Prasad The Dollar Trap: How the U.S. Dollar TIghtened its Grip on Global Finance, by Eswar S. Prasad WEBSITE: https://www.futureofmoneybook.com/

2025 has been a hugely consequential year, with troubling assaults on the Rule of Law in the US as well as challenges to international law in the Middle East and Ukraine. Closer to home, the UK justice system continues to creak under the weight of the backlog. With so much happening, the Law & Disorder team gather (remotely) one last time for 2025, to look back over the past 12 months and ahead to the start of a new year. Are our legal norms being irreparably eroded? Or can the rules-based order reassert itself?If you want to enter the competition to win a signed copy of Edward Stourton's new book, please send your entries to lawanddisorderfeedback@gmail.com!Law and Disorder is a Podot podcast.Hosted by: Charlie Falconer, Helena Kennedy, Nicholas Mostyn.Executive Producer and Editor: Nick Hilton.Associate Producer: Ewan Cameron.Music by Richard Strauss, arranged and performed by Anthony Willis & Brett Bailey. Hosted on Acast. See acast.com/privacy for more information.

It's not always easy to understand it.

In youth, binge eating is often marked by loss of control eating (LOC-E), defined as difficulty stopping eating and persistent, compulsive food-seeking behaviors that occur even in the absence of physical hunger. In this podcast, Dr. Aaron Keshen discusses his article, titled, "Reduction of Loss of Control Eating in Youth With Attention-Deficit/Hyperactivity Disorder Following Initiation of Stimulant Medication: A Prospective Study." In their article, the authors describe a prospective observational study that aimed to examine changes in LOC-E over a 3-month period in youth with comorbid attention-deficit/hyperactivity disorder and LOC-E who initiated stimulant medication.   The other authors are Colby Price, Elena Koning, Anastasia L. Harris, Nami Trappenberg, Anja Hilbert, Sara Bartel, Jill Chorney, Laura Dixon, Joseph Sadek, Guido K.W. Frank, Victoria Taylor, Wanda Rasmussen, Hanif Chatur, Drew Yamada, and Stuart B. Murray. The article is published in the January-February 2026 issue of The Journal of Clinical Psychopharmacology. doi: 10.1097/JCP.0000000000002106

Depression, also known as major depressive disorder, is projected to be the number 1 cause of disease burden by 2030. We look at the causes and risk factors, the DSM 5 diagnostic criteria, and the treatment of depression.PDFs available here: https://rhesusmedicine.com/pages/psychiatryConsider subscribing (if you found any of the info useful!): https://www.youtube.com/channel/UCRks8wB6vgz0E7buP0L_5RQ?sub_confirmation=1Patreon: https://www.patreon.com/rhesusmedicineBuy Us A Coffee!: https://www.buymeacoffee.com/rhesusmedicineTimestamps:0:00 Major Depressive Disorder0:23 DSM 5 Criteria - Major Depressive Disorder 1:58 Depression Causes & Risk Factors 3:10 Depression Pathophysiology 4:28 Depression Epidemiology 4:59 Depression Diagnosis 5:39 Depression Treatment LINK TO SOCIAL MEDIA: https://www.instagram.com/rhesusmedicine/Reference:Bains, N. & Abdijadid, S., 2023. Major Depressive Disorder. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. [online] Available at: https://www.ncbi.nlm.nih.gov/books/NBK559078/. NCBIPsycom, 2025. DSM-5 depression criteria – Major Depressive Disorder. [online] Available at: https://www.psycom.net/depression/major-depressive-disorder/dsm-5-depression-criteria.Wikipedia, 2025. Major depressive disorder. [online] Available at: https://en.wikipedia.org/wiki/Major_depressive_disorder.National Institute of Mental Health (NIMH), 2025. Depression. [online] Available at: https://www.nimh.nih.gov/health/topics/depression.Bondy, B., 2002. Pathophysiology of depression and mechanisms of treatment. Dialogues in Clinical Neuroscience, 4(1), pp.7–20. [online] Available at: https://www.tandfonline.com/doi/full/10.31887/DCNS.2002.4.1/bbondy. Taylor & Francis OnlineDisclaimer: Please remember this podcast and all content from Rhesus Medicine is for educational and entertainment purposes only and is not a guide to diagnose or to treat any form of condition. The content is not to be used to guide clinical practice and is not medical advice. Please consult a healthcare professional for medical advice.

As the days grow shorter and sunlight fades, millions of people experience a drop in energy, motivation, and mood — a condition known as Seasonal Affective Disorder (SAD). In this episode of the Craft Therapy Network Podcast, host Earl is joined by wellness researcher and creative healing advocate Mariam to unpack why seasonal depression happens and how to navigate it naturally.Together, they explore how reduced sunlight impacts serotonin and melatonin levels, throwing off sleep cycles and emotional balance. But more importantly, they share practical, accessible tools to help you feel better — without relying solely on medication.This episode covers natural light strategies, gentle movement, and the importance of maintaining daily rhythm during the fall and winter months. You'll learn how nutrition plays a key role in emotional health, including how functional mushrooms like Cordyceps can support natural energy and reduce winter fatigue. The conversation also dives deep into craft therapy — using creativity as a powerful tool to shift mindset, reduce rumination, and actively create emotional light during darker seasons.From building cozy wellness spaces and handmade journals to designing routines that blend mindfulness and play, this episode is a reminder that winter doesn't have to feel heavy. You can design your season with intention, creativity, and care.Whether you're struggling with SAD or simply want to feel more balanced as the seasons change, this episode offers grounded insights and practical inspiration to help you stay connected, creative, and well.

In part four of this seven-part series on FND, Dr. Jon Stone and Dr. Gabriela Gilmour discuss the diagnostic explanation.  Show citation:  Stone J. Functional neurological disorders: the neurological assessment as treatment. Pract Neurol. 2016;16(1):7-17. doi:10.1136/practneurol-2015-001241  Gilmour GS, Lidstone SC. Moving Beyond Movement: Diagnosing Functional Movement Disorder. Semin Neurol. 2023;43(1):106-122. doi:10.1055/s-0043-1763505  Podcast transcript:  Dr. Gabriela Gilmour: This is Gabriela Gilmour with the Neurology Minute. Jon Stone and I are back to continue with part four, of seven, of our series on functional neurological disorder. Today we will focus on the diagnostic explanation. So many patients have never heard of FND before receiving this diagnosis. Can you share how you explain the diagnosis to your patients? Dr. Jon Stone: So I'm aware that many neurologists do find this difficult. And I have to say, having thought about it for 20 years or so now, I think the answer is, don't be weird. Do what you normally do with any condition, when you explain it to patients. I think what goes wrong is that people see FND as something weird and other, and they start to do weird things like telling people that their scans are normal, or telling them what they don't have before they've started to tell them what they do. If you go with the normal rules of explanation, first of all, starting by giving it a name that you prefer, so you've got FND, or try and be specific if you can. You've got functional seizures, functional movement disorder. Give it a name to start with. Don't sort of spend a long time beating around the bush before you do that. Talk a bit about why you've made the diagnosis, because that's what you normally do. So if someone's got a weak leg, show them their Hoover's sign. I think actually showing people their physical signs is probably one of the most powerful things you can do, brings the diagnosis away from the scanner and into the clinic room. And also, they can see in front of them the potential for improvement. So it feeds forward into treatment. Yes, you might need to explain why they don't have some other conditions that they're worried about, but you can leave discussions about why it's happened for later. I think what tends to go wrong is people jump into that too early. So the bottom line, just do what you normally do and things generally go a lot more smoothly. Dr. Gabriela Gilmour: And when you're providing the diagnostic explanation, it can be really helpful to link the patient's experience and their symptoms to the diagnosis. And so, I wonder how you integrate that piece into your diagnostic explanation, or how you tailor your explanation to an individual patient. Dr. Jon Stone: Yeah, I think tailoring is really important here. And this is where obviously if you've done your assessment, so helpful to ask the patient is, "Well, what do you think's wrong? What things were you worried about? " Some people say, "Look, I'm really worried I've got MS." Or some people say, "I haven't got FND. I've read about that. " Or sometimes people are wondering if they've got FND. So, you've got to try and tailor it to what the person is expecting and particularly previous experiences. If they're telling you how angry they were about doctors A, B, and C, then obviously you want to use that and try not to end up with the same outcome. Why would there be a problem with this diagnosis? It's because they haven't heard about it, because they've got misconceptions about it. Do they feel that this diagnosis would be saying it's all in their mind or something like that? You might need to be explicit about that. But I think this links into how, it's not just about the diagnostic label, it's about a formulation, which is something we don't think about much in neurology. So there's a label for what's wrong, but in FND, a formulation, why have you got FND, in your particular case, is what we're sort of moving on to there based on the story that you've heard. Dr. Gabriela Gilmour: Yeah. And I think in my experience and in working with trainees, really just practicing, saying it, is so important and saying it in a way that feels honest and correct to you as a clinician. Dr. Jon Stone: Yeah, absolutely. Dr. Gabriela Gilmour: So we will be back for more Neurology Minute episodes to continue our discussion on FND. Next, we're going to be talking about treatment. Thanks for listening.

Recorded 2025-12-18 02:02:05

When you create order in one part of your business, disorder will show up somewhere else and that's not a sign of failure, it's the science of growth. In this episode, we break down the law of entropy and explain why the most successful leaders learn to anticipate chaos, secure team buy-in and rebuild systems as their business scales. You'll hear real examples of what disorder looks like and the risk of lack of engagement, uneven workloads and resistance. If you're growing, leading change, or planning a big shift in your business, this episode will give you the mindset and tools to manage disorder instead of being blindsided by it.   GET MY BOOK! From First Date to Forever; How to Market Like A Matchmaker: https://joinmya.com/from-first-date-to-forever-book    POWERED BY:  JOIN mya! joinmya.com   LET'S CONNECT! BTT Instagram: https://www.instagram.com/beyondthetechnique MYA Instagram: https://www.instagram.com/join_mya/    FOLLOW KATI WHITLEDGE Instagram: https://www.instagram.com/katiwhitledge/ Get my favorite bio-hacking products: CLICK HERE   SPONSORS Join the PBA: https://www.probeauty.org/

Welcome to Real Food Recovery, a podcast created by two lifelong processed food addicts with over 100 years of addiction (and recovery) between them. Paige Alexander and Jamie Morgan Reno use their Real Food Recovery podcast and social media channels to share their struggles, lessons learned, tools, tips, and resources that freed them from decades of food addiction, obsession, and loss.   Join us as we welcome Dr. Claire Wilcox, an addiction psychiatrist and psychiatrist, a former internist, who has worked in a variety of clinical settings, including eating disorder treatment facilities, addiction treatment centers, and general psychiatric practice. She is also adjunct faculty at the University of New Mexico and associate professor of translational neuroscience at the Mind Research Network, where she has studied the brain chemistry of addictive disorders and the effects of addiction treatment on brain function. She is the author of the textbook Food Addiction, Obesity and Disorders of Overeating: An Evidence-Based Assessment and Clinical Guide (2021) and the self-help book, Rewire Your Food Addicted Brain: Fight Cravings and Break Free from a High-Sugar Ultra-Processed Diet, both available for purchase at major retailers. You can find out more about Dr. Wilcox at www.wilcoxmd.com.   In every Real Food Recovery episode, Paige and Jamie take time to answer viewer questions about processed food addiction, obsession, and recovery. Be sure to submit yours on their YouTube Channel or Facebook Page. You can also follow Real Food Recovery on Instagram (@realfoodrecovery4u), TikTok (@realfoodrecovery) or at www.realfoodrecovery4u.com.  

Former U.S. Ambassador to Russia Michael McFaul joins leading democracy scholar Larry Diamond for a critical discussion on the intensifying global struggle between authoritarianism and democracy. Drawing on decades of experience in diplomacy, national security, and democracy studies, they examine how autocratic regimes are reshaping the international order—and what democratic societies must do to respond.Michael McFaul served for five years in the Obama administration, first as Special Assistant to the President and Senior Director for Russian and Eurasian Affairs at the National Security Council, and later as U.S. Ambassador to the Russian Federation (2012–2014). He is a Professor of Political Science at Stanford University and Director and Senior Fellow at the Freeman Spogli Institute for International Studies.Larry Diamond is a leading scholar of democracy studies and Senior Fellow at the Freeman Spogli Institute for International Studies at Stanford University. His work has shaped global understanding of democratic development, backsliding, and resilience.This event is part of the America at a Crossroads virtual series, founded by Jews United for Democracy & Justice, bringing leading voices together to examine the most urgent challenges facing democracy at home and abroad.

With Christmas just around the corner, the Disorder of the Heron take on The Bench Warmers (a team of Ringers) in the LORRR quiz to end them all. Dice Company: Small Embers is a cinematic Dungeons & Dragons actual play podcast that blends immersive storytelling, high production values, and emotional character drama. Join a cast of storytellers as they navigate political intrigue, ancient magic, and moral consequences in a world on the brink of collapse. Each episode follows the adventuring party through the dark and richly detailed continent of Aethelon; a place of broken empires, cursed relics, and gods long forgotten. Combining deep narrative roleplay with expert sound design and original scoring, Small Embers delivers the atmosphere of a prestige audio drama with the heart and spontaneity of D&D. Whether you love fantasy podcasts, D&D campaigns, or character-driven storytelling, Dice Company: Small Embers is the perfect mix of epic adventure and intimate human storytelling. Perfect for fans of Critical Role, Dungeons & Daddies, and The Adventure Zone.

In part three of this seven-part series on FND, Dr. Jon Stone and Dr. Gabriela Gilmour discuss causes of functional neurologic disorder.  Show citation:  Hallett M, Aybek S, Dworetzky BA, McWhirter L, Staab JP, Stone J. Functional neurological disorder: new subtypes and shared mechanisms. Lancet Neurol. 2022;21(6):537-550. doi:10.1016/S1474-4422(21)00422-1 Show transcript:  Dr. Gabriela Gilmour: This is Gabriela Gilmour with the Neurology Minute. Jon Stone and I are back to continue with part three of our seven-part series on functional neurological disorder. Today, we will focus on the causes of FND. So Jon, there have been many advances in our understanding of the mechanism of FND in the last 10, 15 years. And so what do we know about this now? Dr. Jon Stone: I think the key message I want to get across here is that whereas previously we had a very psychiatric, purely psychiatric view of FND, it used to be called conversion disorder, what we've got now is a multi-perspective view of the mechanisms, which mean that we can understand FND at a kind of neural level or brain circuit level, but we can also still retain the importance of psychological factors, traumatic events. And I think it's also important to separate out, as you've done here with a question, what's the mechanism? How is the symptom happening versus why is it happening? Which often people don't do. So for this question, how is it happening? How is it that somebody, for example, gets a weak leg? Well, at a very simple level, their brain is disconnecting from their leg and that's what dissociation is. And you can explain that to patients at sort of brain circuit level. We've learned that there are disruptions probably in the circuits in our brain that relate to that sense of agency, the parts of our brain that tell us that our bodies belong to us. And people are particularly interested in an area called the temporary parietal junction. And at a higher broader level, people are particularly interested in the idea that FND is a disorder that you would expect to happen based on our understanding of the brain as a predictive organ. So if the brain spends its time predicting things, maybe in FND what's gone wrong is this is very strong prediction that the leg is weak or that there's a tremor or that a seizure's about to happen that overrides sensory input telling our brain otherwise. Dr. Gabriela Gilmour: And I guess to follow into that, you mentioned what is going on. So now can you talk a little bit about why somebody might develop FND or the etiology of FND? Dr. Jon Stone:  I think this helps clinically as well as neurologists, because we can talk about mechanism as we would, for example, with MS as inflammation, but why is there inflammation? So okay, the brain's gone wrong, but why has it gone wrong? And there we need a much more complex view of multiple range of risk factors, predisposing, precipitating, and perpetuating that we know are associated with FND, but vary a lot from person to person. So no one person's the same. If you've had traumatic experiences in the past, that will make you more prone to dissociation. If you've had other functional disorders, if you have almost certainly some forms of genetics make people predisposed. And then as we said in the last episode, having another neurological condition, so having migraine aura, a physical injury, an infective illness, these are powerful reasons to trigger neurological symptoms. And it's not so much why they happen. It's more why do they get there and get stuck? We all probably have transient functional symptoms actually, but why they get stuck in people with FND for various reasons to do with the way their brains work or their past experiences, or sometimes what happens to them in medical systems. So developing a very open idea about why someone might have FND really helps you, I think, explain that back to patients and produce individual sort of formulations of the problem. Dr. Gabriela Gilmour: Yeah. And I often say to my patients, "I don't know exactly why you, why today have this." And that's true in medicine in general. We actually often don't know why anybody develops any medical condition with a few exceptions, but we know about risk factors really. Dr. Jon Stone: Absolutely. It's one of the reasons I hate the term medically unexplained. Actually, I think FND is perhaps more explained in some ways than some of the other conditions like multiple sclerosis and ALS that we actually deal with where we really don't know why they happen. Dr. Gabriela Gilmour: Well, we will be back for more Neurology Minute episodes to continue our discussion on FND. Thanks for listening. 

Traumatic brain injuries (TBI) like concussions are not uncommon, especially in children and older adults. These injuries can have both short-term and lasting effects on the brain, but what about their impact on cognitive function? Dr. Deling He of UW–Madison's Cognitive-Communication in Aging and Neurogenic Disorders Laboratory (CCANDL) lab joins the podcast to discuss her research on the connections between TBI, speech pathology and cognition and what her study findings mean for people with a history of TBI. Guest: Deling He, PhD, postdoctoral research associate, Cognitive-Communication in Aging and Neurogenic Disorders Laboratory, Department of Communication Sciences and Disorders, UW–Madison Show Notes Read the study from the University of California, San Francisco (UCSF), “Traumatic Brain Injury Strikes 1 in 8 Older Americans,” mentioned by Dr. Chin at 0:30 on the UCSF website. Learn more about Dr. He's study in the article, “TBI linked to long-term cognitive decline in preclinical Alzheimer's disease,” published on Healio's website. Learn more about the Cognitive-Communication in Aging and Neurogenic Disorders Laboratory (CCANDL) on their lab website. Learn more about Dr. He on the CCANDL website. Connect with us Find transcripts and more at our website. Email Dementia Matters: dementiamatters@medicine.wisc.edu Follow us on Facebook and Twitter. Subscribe to the Wisconsin Alzheimer's Disease Research Center's e-newsletter. Enjoy Dementia Matters? Consider making a gift to the Dementia Matters fund through the UW Initiative to End Alzheimer's. All donations go toward outreach and production.

Shining a Light on Seasonal Affective Disorder with Lee Anne Walmsley - BWR: Vodcast Ep. 113

For years, Dan Joseph's life was governed by his BDD and a strict set of rules and rituals designed to camouflage his perceived flaws. Today, he truly believes it doesn't matter how he presents to people. And the next day is no longer to be survived, but to be lived.

Nicola Longo MD, PhDProfessor and Vice Chair of Human Genetics,Allen and Charlotte Ginsburg Chair in Precision Genomic Medicine,Division of Clinical Genetics, Department of Human Genetics,University of California at Los Angeles (UCLA), Los Angeles, CA, USAMark Roberts, MDProfessor and Consultant Neurologist,University of Manchester, Manchester, UKResearch Lead for Adult Metabolic Medicine at Salford Care Organisation, Manchester, UKDrs. Longo and Roberts discussed the current status of gene therapies in rare neuromuscular disorders in this eight-part podcast series. This is derived from the symposium that was presented at World Symposium 2025 in San Diego, California on February 4th through 7th, 2025, and is intended for healthcare professionals only.This podcast includes information about investigational compounds that do not yet have a regulatory approval or authorization for a specific indication. The safety and efficacy of the agents under investigation have not been established, and contents of this podcast shall not be used in any manner to directly or indirectly promote or sell the product for unapproved uses.The views, thoughts, and opinions expressed in this presentation belong solely to the author and are subject to change without notice. The contents of this presentation do not constitute an endorsement of any product or indication by Astellas.In this part, Dr. Roberts will discuss lysosomal disorders and the potential for gene therapies.Mark Roberts, MDI'm going to give an overview of what is gene therapy, emphasizing the current challenges and the development issues and needs that there will be as we try and enable gene therapy for our patients, particularly those with lysosomal storage disorders.I'm going to try and make a case for why lysosomal storage disorders are an extremely good group of conditions for the potential benefits of gene modifying therapies. Firstly, whilst we all recognize that these conditions are inherently individually rare, they're certainly severe. Collectively, with over 70 LSD disorders, 1 in 5,000 may be afflicted by these conditions ultimately in their life and can be detected, for example, by newborn screening programs.Secondly, there's certainly a significant clinical burden with these patients with the current standard of care, so a large unmet need exists. Existing enzyme replacement therapies have undoubtedly changed the natural history of many of these conditions, but there are limitations and often initial benefits and later deteriorations.Unfortunately, for most lysosomal storage disorders, it's only symptomatic treatments and indeed, care that is available for these patients with no specific treatment. Thirdly, these conditions are extremely well-characterized, monogenic singleton and problems of inborn errors of metabolism. We know the functional protein that is deficient in these conditions. Because of that, and knowing that these are critical for lysosomal function, and using preclinical models, we can model the potential benefits of gene therapies very well in a number of systems, including, of course, soon, muscle chip experiments as well.Finally, with these conditions, they may potentially be really useful targets whilst not perhaps curing the condition, at least ameliorating the phenotype, and enabling the addition of other treatments as well, potentially. I've noted, some of these therapies can be directly delivered to certain tissues, so muscle tissue, which is my main interest, but also, crucially, the central nervous system, which is very important when we consider ameliorated phenotypes, for example, treated by enzyme replacement therapy, but where the children who become the adults have significant learning disability as a major component to their problems.In the next part, Dr. Roberts will discuss vectors, different strategies, modes of administration, and targets in gene replacement therapies.

Are we witnessing rising Islamic militancy in Bangladesh? Or could it become a model for other developing countries? A nationwide celebration is underway. It's Victory Day for Bangladesh's 176 million people. Fifty-four years ago today -- December 16th, 1971 -- the former state of East Pakistan became the modern, independent nation of Bangladesh.   But few people are pleased with the trajectory Bangladesh is currently on. What's been happening this past 15 months has shaken this country to its core. On August 5th, 2024 protests over government job quotas escalated into a wider anti-government movement, with a resulting violent crackdown leading to the ousting of the long-time ruler, Sheikh Hasina. She now faces the death penalty if she returns. Her whole political party, the Awami League, has been banned too.   Now the Muslim-majority state faces perhaps the most significant fork-in-the-road moment since its independence. The February 2026 election. Can the caretaker leader and Nobel Peace Prize laureate Muhammad Yunus pull it off? Will it be free and fair?  It is possible that stability and democracy will be restored. It is also possible that an Islamist takeover and the cancellation of Democracy will ensue. To find out how the election could not only reshape contemporary Bangladesh's political foundations but also South Asian stability, security cooperation and geopolitical rivalries, Disorder co-host Mark Lobel is joined by three experts on the ground in the country. 1- Debapriya Bhattacharya-- Economist, public policy analyst and Distinguished Fellow at the Centre for Policy Dialogue in Dhaka, Aasha Mehreen Amin -- joint editor at The Daily Star, and Iftekharuz Zaman -- Executive Director of Transparency International Bangladesh. Although we don't hear about it much in the Western press, investors and policymakers the world over certainly have their eyes peeled on South Asia's second largest economy and what it decides to do next. We hope you the Orderers enjoy this exclusive journalistic content.  If you like more deepdives like this and appreciate the effort we are putting in please: PLEASE join our Mega Orderers Club, and get ad free listening, early episode releases, bonus content and exclusive access to live events, visit https://disorder.supportingcast.fm/  Producer: George McDonagh Subscribe to our Substack - https://natoandtheged.substack.com/ [Join the pay for substack for the 8 Jan event] Disorder on YouTube - https://www.youtube.com/@DisorderShow Show Notes Links: You can get in touch with Mark, to host or speak at your event here: https://www.mark-lobel.com/getintouch  Aasha's 'No Strings Attached' column: https://www.thedailystar.net/author/aasha-mehreen-amin  National Survey of Bangladesh: https://www.iri.org/resources/national-survey-of-bangladesh-september-october-2025/  Citizen's Platform for SDGs, Bangladesh: https://bdplatform4sdgs.net/  Pls Join the Mega Orderers Club for ad-free listening and early release of the episodes, via this link: https://disorder.supportingcast.fm/ Join us at our live event in RUSI on January 8th https://my.rusi.org/events/disorder-podcast-live-what-disorder-will-2026-bring.html (You need to join RUSI or the Mega Orderers Club or Paid for Substack to attend) Learn more about your ad choices. Visit megaphone.fm/adchoices

Evolutionists claim that the 2nd law of thermodynamics-all closed systems become less ordered over time-doesn't apply to the evolution of life on earth because Earth is not a closed system.  This idea is discussed in light of available research.

Rush University Medical Center's newly established Dizziness Clinic brings together specialists in otolaryngology, neurology, audiology, and vestibular therapy to evaluate and treat patients with persistent or unexplained dizziness.   Co-directors Mohamed Elrakhawy, MD, an otolaryngologist, and Jesse Taber, MD, a neurologist, discuss how the clinic operates, why cross-disciplinary collaboration matters, and what diagnostic and therapeutic strategies are most effective for this challenging patient population.  

2025-12-15 | UPDATES #079 | “Pax Americana is over.” We've known this for a while, but Chancellor Merz's speech still dropped like a bomb going off. And it was a warning flare from the centre of Europe's security architecture. In this episode we cover Chancellor Merz's speech, the Berlin peace push, and the emerging European fear that Washington is no longer an ally — possibly even adversary.This weekend, Chancellor Friedrich Merz told a party congress in Munich that Europe must brace for a fundamental shift in its relationship with the United States — because the American-guaranteed peace that defined Europe's postwar order is, in his words, “largely over.” (Reuters)----------SOURCES: Reuters (Dec 13–14, 2025): Merz “Pax Americana” quote; Berlin ceasefire talks; U.S. plan terms.Reuters (Dec 9, 2025): U.S. NSS attack on European democracies; “cultivating resistance” inside EU; Merz response. Reuters (Dec 14, 2025): AfD lawmaker calls for U.S.–German nationalist alliance at MAGA gala.The Guardian (Dec 15, 2025): Berlin summit framing; European fears U.S. plan favours Russia. Ulrich Speck (Substack, Dec 14, 2025): European reaction, “shock” and hostility perception.----------Silicon Curtain is a part of the Christmas Tree Trucks 2025 campaign - an ambitious fundraiser led by a group of our wonderful team of information warriors raising 110,000 EUR for the Ukrainian army. https://car4ukraine.com/campaigns/christmas-tree-trucks-2025-silicon-curtainThe Goal of the Campaign for the Silicon Curtain community:- 1 armoured battle-ready pickupWe are sourcing all vehicles around 2010-2017 or newer, mainly Toyota Hilux or Mitsubishi L200, with low mileage and fully serviced. These are some of the greatest and the most reliable pickups possible to be on the frontline in Ukraine. Who will receive the vehicles?https://car4ukraine.com/campaigns/christmas-tree-trucks-2025-silicon-curtain- The 38th Marine Brigade, who alone held Krynki for 124 days, receiving the Military Cross of Honour.- The 1027th Anti-aircraft and artillery regiment. Honoured by NATO as Defender of the Year 2024 and recipient of the Military Cross of Honour.- 104th Separate Brigade, Infantry, who alone held Kherson for 100 days, establishing conditions for the liberation of the city.- 93rd Brigade "Kholodnyi Yar", Black Raven Unmanned Systems Battalion ----------SILICON CURTAIN FILM FUNDRAISERA project to make a documentary film in Ukraine, to raise awareness of Ukraine's struggle and in supporting a team running aid convoys to Ukraine's front-line towns.https://buymeacoffee.com/siliconcurtain/extras----------SILICON CURTAIN LIVE EVENTS - FUNDRAISER CAMPAIGN Events in 2025 - Advocacy for a Ukrainian victory with Silicon Curtainhttps://buymeacoffee.com/siliconcurtain/extrasOur events of the first half of the year in Lviv, Kyiv and Odesa were a huge success. Now we need to maintain this momentum, and change the tide towards a Ukrainian victory. The Silicon Curtain Roadshow is an ambitious campaign to run a minimum of 12 events in 2025, and potentially many more. Any support you can provide for the fundraising campaign would be gratefully appreciated. https://buymeacoffee.com/siliconcurtain/extras----------SUPPORT THE CHANNEL:https://www.buymeacoffee.com/siliconcurtainhttps://www.patreon.com/siliconcurtain----------

Short winter days can trigger seasonal affective disorder — especially in children — but resources from FYIdaho are available to help families cope. 

Now we command you, brethren, in the name of our Lord Jesus Christ, that ye withdraw yourselves from every brother that walketh disorderly, and not after the tradition which they received of us.2 Thessalonians 3:6 ASV

Send us a textToday, we discuss Obsessive Compulsive DisorderCheck us outgraceintheshadowsor.orgdrjonathan@graceintheshadowsor.org(251) 244-4645*If you are searching for a clinical counselor and you live in Alabama,Idaho,  Florida, Virginia, South Carolina, or North Carolina, Dr. Jonathan Behler would be happy to see you as a client! He does all counseling virtually through a secure portal. He will also work with you on payments - don't let finances keep you from getting counseling!Donate to support a church/school multipurpose building and a motorcycle for the missionary to the Maasai tribe. https://www.purecharity.com/fundraisers/sc-africa-talley  (We only need to raise about $4000 for this mission.)Support the show

Should misconduct be taken into account when an equitable division of assets is being attempted following a divorce?This is an extra special episode where we joined forces with the well-known legal podcast, Law & Disorder, hosted by Charlie Falconer (Labour peer and former Lord Chancellor), Baroness Helena Kennedy, Sir Nicholas Mostyn.  Sadly, Charlie Falconer could not join us on the day of the recording.Together they talk about financial remedy cases as it was, is and could possibly be, as our understanding of complex issues like domestic abuse and coercive control evolve.Our listeners will be especially interested to hear Sir Nicholas Mostyn's insights as he reflects on this complex issue.

As the days grow shorter and the Montana winters settle in here in Bozeman, many of us feel that familiar drag—low energy, persistent sadness, cravings for comfort foods, or just a sense that motivation has packed up and left for sunnier skies. If this sounds like you, you're not alone: it's Seasonal Affective Disorder (SAD), a real form of depression that hits reliably with the changing seasons.   In this enlightening episode of Forging Forward, host Adam Thorne and co-host Andy Kemp—two experienced therapists based right here in Bozeman—dive deep into SAD. They break down what it really is (beyond just the "winter blues"), explore common symptoms like oversleeping, social withdrawal, irritability, and carb cravings, and share evidence-based strategies to fight back. From the power of light therapy and circadian rhythm hacks to cognitive behavioral techniques, lifestyle tweaks, and when medication or professional support might make a difference, Adam and Andy offer practical, hopeful insights drawn from their years helping clients thrive through Montana's long winters.   Whether you're noticing these patterns in yourself or someone you care about, this conversation will empower you with tools to reclaim your energy and mood—no matter how gray the sky gets. Tune in and start forging forward toward brighter days!   About the Hosts:   Adam Thorne Psychology Today Profile: https://www.psychologytoday.com/profile/1441965   Andy Kemp Psychology Today Profile: https://www.psychologytoday.com/us/therapists/andrew-andy-kemp-bozeman-mt/879276   If you're struggling with seasonal changes or any mental health concerns, reach out to Adam or Andy for personalized support. Both offer free consultations—book yours today and take the first step toward feeling like yourself again.

Nutritional Disorders – Polio Dr. Richard Ehrhardt Michigan State University

According to the American National Association of Anorexia Nervosa and Associated Disorders, around 9% of the US population are affected by an eating disorder. We've all heard of anorexia, bulimia and binge eating, which are among the most commonly diagnosed. But there is also orthorexia. It's called orthorexia, coming from the Latin words “orthos”, meaning correct and “orexis”, meaning appetite. American doctor Steven Bratman coined the term in 1997. To put it simply, orthorexia is a need to eat healthy at all costs, to the extent that it becomes an obsession. Those affected start cutting out certain foods completely, or even seeing them as dangerous when they're not really. Scientifically speaking, orthorexia isn't recognised as an eating disorder in its own right, at least not yet. So it's hard to find any precise data on how many people are affected. But it's still more dangerous than you might think. Isn't eating healthily recommended by medical professionals? How can I find out if I suffer from orthorexia? ⁠In under 3 minutes, we answer your questions !⁠ To listen to the latest episodes, click here: ⁠Will Star Wars: Andor live up to the hype?⁠ ⁠Why were the queen's bees told of her death?⁠ ⁠Do I have poor blood circulation?⁠ A podcast written and realised by Joseph Chance. First Broadcast: 24/9/2022 Learn more about your ad choices. Visit megaphone.fm/adchoices

Recorded 2025-12-11 02:00:44

In part two of this seven-part series on FND, Dr. Jon Stone and Dr. Gabriela Gilmour discuss pitfalls in the diagnostic process.  Show citation:  Finkelstein SA, Popkirov S. Functional Neurological Disorder: Diagnostic Pitfalls and Differential Diagnostic Considerations. Neurol Clin. 2023;41(4):665-679. doi:10.1016/j.ncl.2023.04.001   

Send us a textScott and John are joined once again by their friend Jeff Kerr (who astute listeners will remember from a very early NMD Podcast dedicated to "Shredders") for a round of "Pick 5". Youtube: https://www.youtube.com/@narcissisticmusicdisorderJoin us on Facebook at NMD podcast group.nmdpodcast@gmail.com to contact us.Tell your friends!!Be sure to Like and Subscribe. Thanks for listening!

Co-hosts Jared Yates Sexton and Nick Hauselman dig into Trump's 2025 National Security Strategy, a 33 page blueprint that reads less like a sober policy document and more like a crypto fascist love letter to white nationalist demographics, spheres of influence, and an American retreat from the postwar liberal order. They break down what it means for NATO, Europe, Russia, China, and why no one in their right mind should ever again trust the United States as a “steady partner” when policy swings on whatever enriches one deeply corrupt old man and his oligarch friends. From there, the guys wade into the Netflix grab for Warner Bros and the rival Ellison–Kushner–Saudi play, talking about how tech money, oil money, and propaganda ambitions are fusing into one giant content machine that cares a lot about control and very little about art. Then it is on to FIFA inventing a fake “Peace Prize” to flatter Trump, the Queller pardon that turned into an open air quid pro quo tantrum, and Marjorie Taylor Greene's sad little image rehab tour on 60 Minutes. Support the show by signing up to our Patreon and get access to the full Weekender episode each Friday as well as special Live Shows and access to our community discord: http://patreon.com/muckrakepodcast Learn more about your ad choices. Visit megaphone.fm/adchoices

In part one of this seven-part series on FND, Dr. Jon Stone and Dr. Gabriela Gilmour discuss the process of diagnosing FND.  Show citation:  Aybek S, Perez DL. Diagnosis and management of functional neurological disorder. BMJ. 2022;376:o64. Published 2022 Jan 24. doi:10.1136/bmj.o64 

Note: This week we're hard at work on Covid Year Six, our annual year in review. This year's show has gotten so big that we're splitting it into two episodes: December 15th: Covid Year Six December 22nd: 2025, Year of Health Fascism and the Anti-State State (working title) —for both of these, go to https://www.patreon.com/deathpanelpod for those episodes and the whole back catalogue of all of our patron episodes So while we get everything together for these shows, today's episode is our discussion from earlier in the year on something that's going to come up in both episodes, but that still deserves its own focus: Trump's executive order “Ending Crime and Disorder on America's Streets," a threat for a mass expansion of carceral sanist policies. We'll see you next week with those episodes! Subscribe on Patreon and hear this week's full patron-exclusive episode here: https://www.patreon.com/posts/145369924 Beatrice, Artie and Tracy discuss the potential impacts of a new Trump executive order called “Ending Crime and Disorder on America's Streets,” which threatens to dramatically expand involuntary psychiatric commitment and make it easier for the government to disappear people off the streets, allegedly in the name of “compassion.” Runtime 1:51:47 We're testing out a new Bookshop.org page (still under construction), where you can find books by past guests and book recommendations from the hosts. Find it here: bookshop.org/shop/deathpanel Show links: Get Health Communism here: bookshop.org/a/118130/9781839765179 Find Tracy's book Abolish Rent here: bookshop.org/a/118130/9798888902523

This episode covers chromosome disorders.Written notes can be found at https://zerotofinals.com/paediatrics/genetics/chromosomedisorders/Questions can be found at https://members.zerotofinals.com/Books can be found at https://zerotofinals.com/books/The audio in the episode was expertly edited by Harry Watchman.

Text at 617-750-9411Please follow us on Instagram!

Feeling the heavy "grey" of the season? You don't have to force happiness today. Join Martin, your Clinical Hypnotherapist, for a gentle 5-minute morning meditation designed to soothe Seasonal Affective Disorder (SAD) and shift your mood instantly.In this episode, we move beyond toxic positivity and use the science of Polyvagal Theory to introduce you to "Glimmers"—the trending antidote to triggers. While triggers push your nervous system into fight-or-flight, glimmers are micro-moments of safety and connection that anchor you back to calm.In just 5 minutes, you will learn to:Retrain Your Brain: Overcome your mind's natural negativity bias by activating your "Glimmer radar." Soothe Winter Blues: Shift your biology from survival mode into "rest and digest" using somatic regulation. Find Magic in the Mundane: Use visualization to spot micro-joys—like the steam of coffee or a winter robin—to spark instant gratitude. Why listen? If you are struggling with seasonal depression, high-functioning anxiety, or just the weight of the dark months, this session offers a practical tool to help you feel safe, warm, and connected. Become a "hunter of glimmers" and find the light that is already there. Featured Affirmations: "I am open to seeing the magic in the mundane." "Safety and joy are available to me right now." "I choose to focus on what warms my heart."

What if the winter depression you've accepted as inevitable is actually one of the most hackable conditions in human biology? In this episode, I'll arm you with the biological weapons to combat “S. A. D” or seasonal affective disorder, explaining how strategic light exposure, targeted nutrition, and circadian rhythm optimization can restore the serotonin and vitamin D3 levels that darker months systematically deplete. CLICK HERE TO BECOME GARYS VIP!: https://bit.ly/4ai0Xwg Thank you to our partners H2TABS: “ULTIMATE10” FOR 10% OFF: https://bit.ly/4hMNdgg BODYHEALTH: “ULTIMATE20” FOR 20% OFF: http://bit.ly/4e5IjsV BAJA GOLD: "ULTIMATE10" FOR 10% OFF: https://bit.ly/3WSBqUa COLD LIFE: THE ULTIMATE HUMAN PLUNGE: https://bit.ly/4eULUKp WHOOP: JOIN AND GET 1 FREE MONTH!: https://bit.ly/3VQ0nzW AION: “ULTIMATE10” FOR 10% OFF: https://bit.ly/4h6KHAD A-GAME: “ULTIMATE15” FOR 15% OFF: http://bit.ly/4kek1ij CARAWAY: “ULTIMATE” FOR 10% OFF: https://bit.ly/3Q1VmkC HEALF: 10% OFF YOUR ORDER: https://bit.ly/41HJg6S RHO NUTRITION: “ULTIMATE15” FOR 15% OFF: https://bit.ly/44fFza0 GOPUFF: GET YOUR FAVORITE SNACK!: https://bit.ly/4obIFDC GENETIC METHYLATION TEST (UK ONLY): https://bit.ly/48QJJrk GENETIC TEST (USA ONLY): ⁠https://bit.ly/3Yg1Uk9 Watch  the “Ultimate Human Podcast” every Tuesday & Thursday at 9AM EST: YouTube: https://bit.ly/3RPQYX8 Podcasts: https://bit.ly/3RQftU0 Connect with Gary Brecka Instagram: https://bit.ly/3RPpnFs TikTok: https://bit.ly/4coJ8fo X: https://bit.ly/3Opc8tf Facebook: https://bit.ly/464VA1H LinkedIn: https://bit.ly/4hH7Ri2 Website: https://bit.ly/4eLDbdU Merch: https://bit.ly/4aBpOM1 Newsletter: https://bit.ly/47ejrws Ask Gary: https://bit.ly/3PEAJuG Timestamps 00:00 Intro of Show 00:50 What is (S. A. D.) Seasonal Affective Disorder? 02:57 Seven Ways to Beat S. A. D.? 06:05 Join The Ultimate Human VIP The Ultimate Human with Gary Brecka Podcast is for general informational purposes only and does not constitute the practice of medicine, nursing or other professional health care services, including the giving of medical advice, and no doctor/patient relationship is formed. The use of information on this podcast or materials linked from this podcast is at the user's own risk. The Content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they may have and should seek the assistance of their health care professionals for any such conditions. Learn more about your ad choices. Visit megaphone.fm/adchoices